Pamela S Becker

36PUBLICATIONS
106CO-AUTHORS
Haematological tumoursMolecular targetsTransplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

|Apr 22, 2026
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Feb 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.

Paul B Koller, Tamer Othman, Dongyun Yang

|Jan 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL.

Ibrahim Aldoss, Shanpeng Li, Jianying Zhang

|Dec 18, 2024
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease.

Amanda Blackmon, Michelle Afkhami, Dongyun Yang

Pageof 6

Frequent Collaborators

7 joint publications

Monzr M Al Malki

7 joint publications

Roland B Walter

6 joint publications

Haris Ali

6 joint publications

Ryotaro Nakamura